Goodpasture syndrome and anti-glomerular basement membrane disease.
Reggiani F, L'Imperio V, Calatroni M, Pagni F, Sinico RA.
Clin Exp Rheumatol. 2023 Apr;41(4):964-974. doi: 10.55563/clinexprheumatol/tep3k5. Epub 2023 Mar 30.
[Review on anti-glomerular basement membrane disease or Goodpasture's syndrome].
Marques C, Plaisier E, Cacoub P, Cadranel J, Saadoun D.
Rev Med Interne. 2020 Jan;41(1):14-20. doi: 10.1016/j.revmed.2019.10.338. Epub 2019 Nov 24.
Goodpasture syndrome.
Kalluri R.
Kidney Int. 1999 Mar;55(3):1120-2. doi: 10.1046/j.1523-1755.1999.0550031120.x.
Diagnosis and classification of Goodpasture's disease (anti-GBM).
Hellmark T, Segelmark M.
J Autoimmun. 2014 Feb-Mar;48-49:108-12. doi: 10.1016/j.jaut.2014.01.024. Epub 2014 Jan 21.
Goodpasture's syndrome.
Bolton WK.
Kidney Int. 1996 Nov;50(5):1753-66. doi: 10.1038/ki.1996.495.
Anti-glomerular basement membrane vasculitis.
Ponticelli C, Calatroni M, Moroni G.
Autoimmun Rev. 2023 Jan;22(1):103212. doi: 10.1016/j.autrev.2022.103212. Epub 2022 Oct 14.
Anti-Glomerular Basement Membrane Disease.
Gulati K, McAdoo SP.
Rheum Dis Clin North Am. 2018 Nov;44(4):651-673. doi: 10.1016/j.rdc.2018.06.011. Epub 2018 Sep 7.
Difficulties in Goodpasture's syndrome diagnosing.
Podzolkov VI, Makhnach GK, Ishina TI, Ponomarev AB, Medvedev ID.
Ter Arkh. 2019 Mar 30;91(3):64-67. doi: 10.26442/00403660.2019.03.000044.
Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome.
Fouka E, Drakopanagiotakis F, Steiropoulos P.
Int J Mol Sci. 2024 May 12;25(10):5278. doi: 10.3390/ijms25105278.
Particularities of Goodpasture Syndrome.
Lübbecke F.
Dtsch Arztebl Int. 2017 Sep 29;114(39):662. doi: 10.3238/arztebl.2017.0662a.
